BIRC5 and ovarian carcinoma: We questioned whether survivin has a role in modulating anoikis resistance in ovarian cancer cells, although mounting evidence has indicated that survivin is frequently overexpressed in human cancers [41] and involved in chemoresistance [42] and metastatic progression [43].